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Evaluation and optimization of medication related fall risk at a community hospital
Giselle Chahili, Pharm.D., Thomas Wolfel, Pharm.D., BCCCP, Erika Dittmar, Pharm.D., BCPS,
Heidi Clarke, Pharm.D., BCCCP

Abstract
Background: Falls occur commonly in older adults at a rate of 3-5 per 1000 beds in healthcare
settings. They can results in increased length of stay, morbidity and mortality, and healthcare
costs. Some risk factors include older age, environmental hazards and medications. Currently at
BHM, patient’s risk for falling is assessed based on Morse Fall Scale (MFS), which does include
drugs as part of its assessment. The purpose of this project is to integrate medication risk
evaluation into our current fall assessment.
Methodology: single-centered, retrospective, IRB-reviewed quality improvement project at
BHM. We included patients over age 18 who fell with at least a minor injury (F2 level) in 2019.
Our primary outcome was to determine prevalence of common high-fall-risk medications
administered in patients who fell and our secondary outcome was to identify pharmacy-led
interventions to decrease fall risk. Since MFS does not include medications as part of its score,
we then evaluated each patient using a medication scoring system with point value of 1-3 for
high-fall-risk medications (point value of 3 is assigned to high-fall-risk medications and point
value of 1 is assigned to low fall risk medications). Any patient with a cumulative score of higher
than 6 is recognized to be at high fall risk.
Results: Primary outcome showed that cardiac agents, followed by opioids, and by
benzodiazepines/sleep aids were the highest administered medications in our patients who fell.
Based on those findings, we identified 29 opportunities where patient could have received lower

doses and/or have had medication scheduling changes in order to reduce fall risk. We are
proposing automatic dose adjustments similar to hydromorphone and zolpidem/temazepam
protocols where pharmacists can reduce starting doses to lowest dose possible for drug naïve
patients. In addition, we are proposing to have medication scoring system to be implemented
into our software so pharmacists are notified if a patient is high risk for falls based on MFS score
and medication score system.
Conclusion: Pharmacists can play a huge role in reducing falls in inpatient settings. Based on our
findings, some opportunities where pharmacists can intervene to reduce risk of falling include
scheduling and automatic dose reductions with medications such as cardiac agents, opioids, and
benzodiazepine/sleep aids.

